ATE282430T1 - Eisenchelator enthaltende antivirale pharmazeutische zusammensetzungen - Google Patents

Eisenchelator enthaltende antivirale pharmazeutische zusammensetzungen

Info

Publication number
ATE282430T1
ATE282430T1 AT00952070T AT00952070T ATE282430T1 AT E282430 T1 ATE282430 T1 AT E282430T1 AT 00952070 T AT00952070 T AT 00952070T AT 00952070 T AT00952070 T AT 00952070T AT E282430 T1 ATE282430 T1 AT E282430T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
iron chelator
compositions containing
containing iron
antiviral pharmaceutical
Prior art date
Application number
AT00952070T
Other languages
English (en)
Inventor
Asbeck Bernt Sweder Van
Johannes Josephus Maria Marx
Original Assignee
Faculteit Geneeskunde Universi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faculteit Geneeskunde Universi filed Critical Faculteit Geneeskunde Universi
Application granted granted Critical
Publication of ATE282430T1 publication Critical patent/ATE282430T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00952070T 1999-08-13 2000-08-09 Eisenchelator enthaltende antivirale pharmazeutische zusammensetzungen ATE282430T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1012825A NL1012825C2 (nl) 1999-08-13 1999-08-13 Farmaceuticum voor de behandeling van virale infecties in het bijzonder van het humane immunodeficiency virus (HIV).
PCT/NL2000/000559 WO2001012168A2 (en) 1999-08-13 2000-08-09 Antiviral pharmaceutical compositions containing iron chelators

Publications (1)

Publication Number Publication Date
ATE282430T1 true ATE282430T1 (de) 2004-12-15

Family

ID=19769735

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952070T ATE282430T1 (de) 1999-08-13 2000-08-09 Eisenchelator enthaltende antivirale pharmazeutische zusammensetzungen

Country Status (6)

Country Link
EP (1) EP1257261B1 (de)
AT (1) ATE282430T1 (de)
AU (1) AU6483100A (de)
DE (1) DE60016044D1 (de)
NL (1) NL1012825C2 (de)
WO (1) WO2001012168A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005516987A (ja) 2002-02-05 2005-06-09 ブリストル−マイヤーズ　スクイブ　カンパニー Ｎ−置換された３−ヒドロキシ−４−ピリジノン化合物およびそれを含む医薬
WO2005055931A2 (en) * 2003-12-03 2005-06-23 University Of Medicine And Dentistry Of New Jersey Method of preventing survival of retrovirally cells and of inhibiting formation of infectious retroviruses
EA034983B1 (ru) * 2014-12-22 2020-04-14 Университет Либре Де Брюссель Композиция, содержащая ванкомицин и орлистат

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors
AU1463992A (en) * 1991-02-28 1992-10-06 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus
AU1672692A (en) * 1991-03-20 1992-10-21 United States of America, as represented by the Secretary, U.S. Department of Commerce, The The use of hydroxamic acid derivatives to inhibit viral replication
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
US5521161A (en) * 1993-12-20 1996-05-28 Compagnie De Developpment Aguettant S.A. Method of treating HIV in humans by administration of ddI and hydroxycarbamide
EP0754039A4 (de) * 1994-04-08 2002-07-17 Procter & Gamble Verfahren zur verwendung von eisen-chelatbildnern zur reduktion der durch freie radikale verursachten schaden bei säugern
WO1997021683A1 (en) * 1995-12-13 1997-06-19 Abbott Laboratories Retroviral protease inhibiting compounds
US5905068A (en) * 1996-09-24 1999-05-18 Abbott Laboratories Retroviral protease inhibiting compounds
US6114312A (en) * 1997-03-07 2000-09-05 Research Institute For Genetic And Human Therapy (R.I.G.H.T.) Method of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitor
NL1009226C2 (nl) * 1998-05-20 1999-11-24 Faculteit Geneeskunde Universi Toepassing van een nucleïnezuur-bindend chemotherapeutisch agens, een farmaceutisch preparaat en een geneesmiddelcombinatie.

Also Published As

Publication number Publication date
WO2001012168A2 (en) 2001-02-22
DE60016044D1 (de) 2004-12-23
WO2001012168A3 (en) 2002-06-06
AU6483100A (en) 2001-03-13
NL1012825C2 (nl) 2001-02-23
EP1257261B1 (de) 2004-11-17
NL1012825A1 (nl) 2001-02-14
EP1257261A2 (de) 2002-11-20

Similar Documents

Publication Publication Date Title
BG103786A (bg) Състав и метод за профилактика и лечение на нiv и други инфекциозни заболявания при човека
MY128458A (en) Antiviral azaindole derivatives
IL215891A (en) Hepatitis C Serine Protease Inhibitors, Pharmaceutical Compounds Containing Them, and Their Use in Preparing Drugs to Treat Hepatitis C Infections
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
EA200701386A1 (ru) Полиалкиленгликоль с остатком для конъюгации биологически активного соединения
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
ATE245641T1 (de) Antivirale pyrimidinderivate
DE50102597D1 (de) Arzneimittel gegen virale erkrankungen
EA200001030A1 (ru) Получение капсул и таблеток быстрорастворяющегося эфавиренза с использованием супердезинтеграторов
SE0100901D0 (sv) New composition
TR200102313T2 (tr) Antiviral maddeler olarak (1R, SíS)-4-(6-amino-9H-purin-9-il)-2-siklopenten-1-metanoln mono-, di ve tri-fosfat esterleri ve fosforamidatlarì
BR0109650A (pt) 3-cianoquinolinas, 3-ciano-1,6-naftiridinas e 3-ciano-1,7-naftiridinas como inibidores da cinase proteìca
DK1458360T3 (da) Pulmonær afgivelse af aminoglycosider
DK1765337T3 (da) Kombination af tenofovir, ritonavir og TMC114
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
WO2001010456A3 (en) Peptides that block viral infectivity and methods of use thereof
HRP20020844B1 (en) Liquid formulations
NL1024676A1 (nl) HIV integrase-remmers, farmaceutische preparaten en methoden voor het gebruik daarvan.
IS6956A (is) Sítrat salt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9-pentaen og lyfjafræðilegar samsetningar af því
WO2001072157A3 (en) Barrier garment system
DE60021413D1 (de) Anti-virale zusammensetzung enthaltend ein palmaria palmata extrakt
ATE245444T1 (de) Pharmazeutische zusammensetzung, enthaltend peg- asparaginase, für die behandlung von hiv infektionen
WO2002085358A3 (en) Antiviral agents and methods of treating viral infections
ATE282430T1 (de) Eisenchelator enthaltende antivirale pharmazeutische zusammensetzungen
WO2002000613A3 (en) Inhibitors of hepatitis b virus infection

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties